|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.54 CNY | +0.20% |
|
-4.55% | -6.94% |
Nanjing Well Pharmaceutical Group Co.,Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 329.83 million compared to CNY 246.45 million a year ago. Net income was CNY 34.6 million compared to CNY 26.31 million a year ago.
Basic earnings per share from continuing operations was CNY 0.26 compared to CNY 0.2 a year ago. Diluted earnings per share from continuing operations was CNY 0.26 compared to CNY 0.2 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -6.94% | 460M | |
| +11.01% | 231B | |
| +5.55% | 102B | |
| +27.38% | 101B | |
| +9.52% | 61.83B | |
| +17.79% | 61.58B | |
| +21.92% | 51.83B | |
| +24.95% | 37.12B | |
| +26.38% | 26.86B | |
| -12.76% | 20.85B |
NANJING WELL PHARMACEUTICAL GROUP CO.,LTD. 
